Results 131 to 140 of about 3,132 (216)

Faricimab Improves Choriocapillaris Perfusion in Diabetic Macular Edema. [PDF]

Ophthalmol Ther
Lee SY, Kim J, Han YE, Lee J.
europepmc   +1 more source

Faricimab: expanding horizon beyond VEGF [PDF]

Eye, 2019
Sharma A., Kumar N., Kuppermann B. D., Bandello F., Loewenstein A.   +4 more
openaire   +4 more sources

Double-dose intravitreal faricimab in resistant neovascular age-related macular degeneration: safety and efficacy

Background Anti-VEGF therapy remains the mainstay treatment for neovascular age-related macular degeneration (nAMD), yet a subset of eyes exhibit resistance to standard treatment regimens.
Soumya Jena, Mohamed Sherif Morsy, Amr Lotfy Ali, William R. Freeman, Nehal Nailesh Mehta, Lingyun Cheng, Dirk-Uwe Bartsch   +6 more
core   +1 more source

Two-year real-world effectiveness of faricimab after treatment switch in neovascular age-related macular degeneration. [PDF]

Int J Retina Vitreous
Ruiz-Medrano J, Zamorano M, de Alboran CM, Ruiz-Moreno JM.   +3 more
europepmc   +1 more source

Early Effect of Intravitreal Faricimab on Hard Exudates in Diabetic Macular Oedema. [PDF]

Ophthalmol Ther
Kumar A, Gandhi B, Ghulakhszian A, Ometto G, Dinah C.   +4 more
europepmc   +1 more source

Short-term morphological and functional outcomes of intravitreal faricimab for chorioretinal disorders: a real-world study in a Chinese population. [PDF]

Front Med (Lausanne)
Jin E, Zhu X, Li S, Zhao M, Miao H, Qian T.   +5 more
europepmc   +1 more source

Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study. [PDF]

Ophthalmol Ther
Mira F, Donato S, Vaz F, Madeira F, Picoto M, Mendes A, Beato J, Torres-Costa S, Pinto C, Oliveira N, Feliciano S, Lume M, Carreiro R, Couto M, Carneiro Â.   +14 more
europepmc   +1 more source

Beyond Central Subfield Thickness: Early Multi-Slice Optical Coherence Tomography Structural Response After Faricimab Injection in Real-World Diabetic Macular Edema. [PDF]

J Clin Med
Liu DY, Wu SL, Hsia NY, Tien PT, Lin CJ, Wang I, Lai CT, Lin JM, Huang YT, Wu BQ, Lin WN, Ku WN, Meng PP, Chen HS, Tsai YY.   +14 more
europepmc   +1 more source

Faricimab in neovascular age-related macular degeneration: aqueous humor cytokine profiling and biomarker correlations. [PDF]

Front Med (Lausanne)
Wan Z, Chen X, Gao F, Shi F, Dai R, Peng Q, Wei Q.   +6 more
europepmc   +1 more source

Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review. [PDF]

Clin Ophthalmol
Mansour HA, Eandi CM, Pichi F, Foster RE, Charbaji SA, Chakraborty D, Ellabban AA, Belotto S, Abu Serhan H, Magnin S, Lopez-Guajardo L, Pérez-Salvador García E, Schwartz SG, Stewart MW, Rey A, Jürgens I, Casella AMB, Upadhyay A, Sheth JU, Lima LH, Sinawat S, Abengoechea S, Capella MJ, Viver Oller S, Elizalde J, Kheir WJ, Mammo D, Barbosa GCS, Villegas VM, Desai A, Tripathy K, Bala S, Mohan N, Elnahry AG, Uwaydat SH, Cherfan DG, Parodi MB, Mansour AM.   +37 more
europepmc   +1 more source